论文部分内容阅读
Objective:To evaluate the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin chemotherapy regimen followed by concurrent chemoradiotherapy or radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma (NPC).